8-K: Jushi Holdings Reports Q3 2025 Growth, Margin Expansion

Jushi Holdings Inc. announced its third-quarter 2025 financial results, showcasing revenue growth and improved gross profit margins driven by operational enhancements and strategic retail expansion.

Summary

• Total revenue reached $65.7 million in Q3 2025, an increase of 6.6% year-over-year and 1.0% sequentially.
• Gross profit grew to $30.7 million, with gross profit margin expanding to 46.7%, up 220 basis points sequentially and 125 basis points year-over-year.
• Net loss for the quarter was $23.7 million, a significant increase from $16.0 million in Q3 2024 and $12.3 million in Q2 2025.
• Adjusted EBITDA was $12.8 million, representing a 19.5% margin, up 23.7% year-over-year but down 6.7% sequentially.
• Cash, cash equivalents, and restricted cash stood at $26.2 million as of September 30, 2025, with net cash flows provided by operations of $6.1 million.
• The company maintained Jushi-branded product sales at 56% of total retail revenue and introduced 821 new SKUs.
• An existing commercial loan was amended, providing an additional $4.0 million, extending maturity to September 2030, and reducing the interest rate floor.
• Jushi opened its 41st nationwide location, Beyond Hello Parma in Ohio, and plans additional store openings in Ohio and New Jersey by year-end 2025 and in H1 2026.

Sentiment

Score: 6

Explanation: While Jushi demonstrated strong revenue growth and significant gross margin expansion driven by operational efficiencies and strategic store openings, the substantial increase in net loss due to fair value adjustments on derivatives and the need to refinance a significant portion of debt within the next year present notable concerns. The positive operational momentum is somewhat offset by these financial challenges.

Positives

• Total revenue increased to $65.7 million, up 6.6% year-over-year and 1.0% sequentially, demonstrating continued topline momentum.
• Gross profit margin expanded significantly to 46.7%, an increase of 220 basis points sequentially and 125 basis points year-over-year, driven by higher production volumes and improved product quality.
• Adjusted EBITDA grew 23.7% year-over-year to $12.8 million, indicating improved operational profitability.
• Net cash flows provided by operations were $6.1 million, reflecting positive cash generation from core business activities.
• The company successfully amended a commercial loan, securing an additional $4.0 million in proceeds, extending the maturity to September 2030, and reducing the interest rate floor, strengthening the balance sheet.
• Strategic retail expansion continued with the opening of Beyond Hello Parma, Ohio, and plans for two more stores by year-end 2025 and one in H1 2026, including entry into the New Jersey market.
• Operational enhancements led to a 13% year-over-year increase in average yields and average THCa potency surpassing the annual target by over 10%.
• Wholesale sales increased 23% sequentially and 12% year-over-year, while retail sales grew 6% year-over-year.

Negatives

• Net loss significantly widened to $23.7 million in Q3 2025, compared to $16.0 million in Q3 2024 and $12.3 million in Q2 2025, primarily due to increased other expenses, net.
• Other income (expense), net, worsened considerably to $(17.2) million in Q3 2025, compared to $(7.2) million in Q3 2024 and $(6.0) million in Q2 2025, largely driven by a fair value loss on derivatives of $6.3 million.
• Adjusted EBITDA decreased 6.7% sequentially from $13.7 million in Q2 2025 to $12.8 million in Q3 2025, and Adjusted EBITDA margin declined from 21.1% to 19.5% sequentially.
• Wholesale revenue in Virginia declined by $1.0 million year-over-year due to lower demand from wholesale partners.
• The company's total deficit increased to $(101.5) million as of September 30, 2025, from $(50.2) million at December 31, 2024.
• Current portion of debt maturing within the next twelve months is $47.3 million, requiring proactive refinancing efforts.

Risks

• Limited operating history of the industry and the Company.
• Risks related to managing the growth of the Company, including completed, pending or future acquisitions or dispositions, potential future impairment of goodwill or intangibles acquired, and/or post-closing disputes.
• Risks related to the continued performance, expansion, and/or optimization of existing operations in California, Illinois, Massachusetts, Nevada, Ohio, Pennsylvania, and Virginia.
• Risks related to the anticipated openings of additional dispensaries or relocation of existing dispensaries subject to licensing approval.
• The Company's history of operating losses and negative operating cash flows.
• Increasing competition in the industry.
• Risks inherent in an agricultural business, such as the effects of natural disasters.
• Reliance on the expertise and judgment of senior management of the Company.
• Risks associated with cannabis products manufactured for human consumption, including potential product recalls.
• Limited research and data relating to cannabis.
• Constraints on marketing products.
• Risk of litigation.
• Insurance-related risks.
• Public opinion and perception of the cannabis industry.
• Risks related to the economy generally.
• Fraudulent activity by employees, contractors, and consultants.
• Risks relating to the Company's current amount of indebtedness.
• Risks relating to not being able to reduce or refinance its debt obligations.
• Reliance on key inputs, suppliers, and skilled labor, and third-party service provider contracts.
• Reliance on manufacturers and contractors.
• Risks of supply shortages or supply chain disruptions.
• Risks relating to pandemics and forces of nature.
• Risks related to the enforceability of contracts.
• Risks related to inflation, the rising cost of capital, and stock market instability.
• Risks relating to U.S. regulatory landscape and enforcement related to cannabis, including political risks.
• Risks relating to anti-money laundering laws and regulation.
• Cannabis-related tax risks and challenges from governmental authorities with respect to the Company's application for Employee Retention Tax Credits (ERC).
• Other governmental and environmental regulation.
• Risks related to proprietary intellectual property and potential infringement by third parties.
• Sales of a significant amount of shares by existing shareholders.
• The limited market for securities of the Company.
• Risks relating to the need to raise additional capital either through debt or equity financing.
• Costs associated with the Company being a publicly-traded company and a U.S. and Canadian filer.
• Risks related to co-investment with parties with different interests to the Company.
• Conflicts of interest and related party transactions.
• Cybersecurity risks.
• Risks related to the Company's critical accounting policies and estimates.
• The Company's ability to continue as a going concern.

Future Outlook

The company expects to continue its topline growth and profitability advancements through ongoing optimization efforts and investments. It plans to open additional stores in Springdale, Ohio, and Little Ferry, New Jersey, by year-end 2025, and a store in Mount Laurel, New Jersey, in the first half of 2026, marking its entry into the New Jersey market. The company is also proactively working to refinance $47.3 million in term loans maturing by September 2026 and remains focused on disciplined execution, strategic scaling, and capturing opportunities in the evolving cannabis industry, while also engaging in policy dialogue for a fair regulatory framework.

Management Comments

• Our third quarter results demonstrate that our optimization efforts and investments are delivering, with both topline growth and profitability advancing as planned.
• Higher yields, enhanced product quality, and more efficient operations are allowing us to serve both our retail network and wholesale partners more effectively, driving stronger sales, expanding margins, and fueling growth across the business.
• This momentum is reflected across our revenue channels, with wholesale sales rising 23% sequentially and 12% year-over-year, and retail sales up 6% year-over-year, primarily driven by new store openings.
• Strong revenue performance and operational execution drove gross profit margin up 220 basis points over last quarter and 125 basis points year-over-year, reaching 46.7%.
• Facility enhancements drove average yields up 13% year-over-year, with average THCa potency surpassing our annual target by more than 10%.
• Our high-return investment projects in Pennsylvania and Virginia continue to expand both cultivation and operational capabilities in response to evolving market demand.
• On the retail side, we further strengthened our presence in Ohio with a sixth store and remain on track for an additional opening by year end. Looking ahead, we expect to launch our first New Jersey store in the fourth quarter, followed by a second location in 2026.
• With 41 strategically located stores and robust operational infrastructure, we have established a strong platform for focused execution and long-term growth in our key markets.
• We remain proactive in identifying opportunities to enhance our balance sheet and optimize our capital structure. The recent mortgage amendment delivered an additional $4.0 million in proceeds, extended the maturity to September 2030, and reduced the interest rate floor, further enhancing our financial position and deepening our relationships with existing financial partners.
• As we near year end, our focus remains on disciplined execution, strategic scaling, and capturing the opportunities ahead as the industry continues to evolve into the new year.
• In parallel, we remain deeply engaged across policy dialogue, regulatory collaboration, and legislative advocacy to support the development of a fair and sustainable regulatory framework for the long-term future of the legal cannabis industry.

Industry Context

The cannabis industry continues to evolve, with companies like Jushi focusing on operational efficiency, strategic retail expansion, and brand portfolio diversification to capture market share. Jushi's efforts to enhance cultivation yields and product quality, alongside its expansion into new adult-use markets like New Jersey, reflect broader industry trends towards optimizing supply chains and capitalizing on state-level legalization. The company's engagement in policy dialogue also highlights the ongoing need for a more stable and favorable regulatory framework for the legal cannabis sector in the U.S.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess Jushi's performance against global benchmarks.

Related Party Transactions

• Debt, net current portion includes related party principal amounts of $15.6 million as of September 30, 2025.
• Debt, net non-current includes related party principal amounts of $25.7 million as of September 30, 2025.
• Notes payable to Sammartino of $21.5 million, for which the Company currently has no obligation to repay.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through strategic expansion and operational improvements, but diluted by increased net loss and potential future capital raises. The increase in total deficit is a concern.
• Employees: Continued growth and expansion, particularly with new store openings, may lead to job creation and stability.
• Customers: Expanded product portfolio with 821 new SKUs and new store openings in Ohio and New Jersey offer more choices and accessibility.
• Creditors: The successful amendment of a commercial loan and proactive steps to refinance maturing debt demonstrate efforts to manage obligations, but the significant debt load and increased net loss warrant close monitoring.

Next Steps

• Open Beyond Hello Springdale, Ohio, and Little Ferry, New Jersey, stores by year-end 2025.
• Launch the first New Jersey store in Q4 2025.
• Open a second New Jersey location (Mount Laurel) in the first half of 2026.
• Complete the refinancing process for $47.3 million in term loans prior to their September 2026 maturity date.
• Continue disciplined execution, strategic scaling, and capturing opportunities in the evolving industry.
• Remain engaged in policy dialogue, regulatory collaboration, and legislative advocacy for the legal cannabis industry.

Key Dates

Recommendation

While Jushi Holdings Inc. demonstrated strong operational improvements, including revenue growth, gross margin expansion, and strategic retail expansion, the significant increase in net loss and the need to refinance a substantial portion of debt within the next year introduce considerable financial uncertainty. The positive momentum in core operations is tempered by these financial challenges, suggesting a "hold" position until there is clearer visibility on debt refinancing and a path to sustained profitability.

Keywords

Cannabis, Multi-state operator, MSO, Jushi Holdings, Financial results, Q3 2025, Revenue, Gross profit, Adjusted EBITDA, Retail, Wholesale, Dispensaries, Ohio, New Jersey, Pennsylvania, Virginia, Cultivation, Marijuana, SEC filing, 8-K